Viatris Depreciation & Amortization 2011-2026 | VTRS

Annual Depreciation & Amortization Viatris

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.8 B	2.89 B	2.74 B	3.03 B	4.51 B	2.22 B	2.02 B	2.11 B	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.51 B	2.02 B	2.79 B

Quarterly Depreciation & Amortization Viatris

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
676 M	593 M	583 M	665 M	575 M	597 M	691 M	584 M	591 M	730 M	-	2.16 B	634 M	736 M	-	3.76 B	2.74 B	1.42 B	-	1.26 B	831 M	415 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.76 B	415 M	1.07 B

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Cumberland Pharmaceuticals CPIX	4.15 M	$ 6.39	8.86 %	$ 94.9 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	84 K	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Cronos Group CRON	14.2 M	$ 2.74	-	$ 1.05 B	Canada
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Harrow Health HROW	1.32 M	$ 32.91	-0.27 %	$ 1.21 B	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Pacira BioSciences PCRX	78.8 M	$ 24.01	2.83 %	$ 1.11 B	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Bausch Health Companies BHC	1.21 B	$ 5.53	1.01 %	$ 2.05 B	Canada
Organogenesis Holdings ORGO	15.3 M	$ 2.59	-2.82 %	$ 328 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.05	0.96 %	$ 113 M	Canada
Solid Biosciences SLDB	1.64 M	$ 6.77	2.27 %	$ 592 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 1.09	-1.36 %	$ 1.35 M	USA
Jupiter Wellness JUPW	654 K	-	-	$ 33.6 M	USA
Tilray TLRY	35.7 M	$ 5.43	2.55 %	$ 3.36 B	Canada
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Evolus EOLS	7.51 M	$ 6.06	-0.49 %	$ 391 M	USA
Emergent BioSolutions EBS	95.8 M	$ 8.98	6.27 %	$ 480 M	USA
Veru VERU	152 K	$ 2.35	0.17 %	$ 34.4 M	USA
Neoleukin Therapeutics NLTX	3.04 M	-	-	$ 193 M	Canada
Assertio Holdings ASRT	30 M	$ 23.45	0.04 %	$ 150 M	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
cbdMD YCBD	361 K	$ 0.74	-2.58 %	$ 2.98 M	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 6.91	-1.85 %	$ 273 M	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	580 K	$ 0.7	-3.84 %	$ 35 M	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Zomedica Corp. ZOM	2.06 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	2.19 M	$ 0.76	-4.4 %	$ 27.3 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	1.5 M	$ 0.76	0.29 %	$ 3.26 M	China
TherapeuticsMD TXMD	384 K	$ 2.1	-0.94 %	$ 24.3 M	USA